389 related articles for article (PubMed ID: 28266048)
1. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.
Mooney SM; Talebian V; Jolly MK; Jia D; Gromala M; Levine H; McConkey BJ
J Cell Biochem; 2017 Sep; 118(9):2559-2570. PubMed ID: 28266048
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.
Cieply B; Farris J; Denvir J; Ford HL; Frisch SM
Cancer Res; 2013 Oct; 73(20):6299-309. PubMed ID: 23943797
[TBL] [Abstract][Full Text] [Related]
3. GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.
Chung VY; Tan TZ; Tan M; Wong MK; Kuay KT; Yang Z; Ye J; Muller J; Koh CM; Guccione E; Thiery JP; Huang RY
Sci Rep; 2016 Feb; 6():19943. PubMed ID: 26887977
[TBL] [Abstract][Full Text] [Related]
4. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
5. Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer.
Werner S; Frey S; Riethdorf S; Schulze C; Alawi M; Kling L; Vafaizadeh V; Sauter G; Terracciano L; Schumacher U; Pantel K; Assmann V
J Biol Chem; 2013 Aug; 288(32):22993-3008. PubMed ID: 23814079
[TBL] [Abstract][Full Text] [Related]
6. A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
Preca BT; Bajdak K; Mock K; Lehmann W; Sundararajan V; Bronsert P; Matzge-Ogi A; Orian-Rousseau V; Brabletz S; Brabletz T; Maurer J; Stemmler MP
Oncotarget; 2017 Feb; 8(7):11530-11543. PubMed ID: 28086235
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2.
Somarelli JA; Shetler S; Jolly MK; Wang X; Bartholf Dewitt S; Hish AJ; Gilja S; Eward WC; Ware KE; Levine H; Armstrong AJ; Garcia-Blanco MA
Mol Cell Biol; 2016 Oct; 36(19):2503-13. PubMed ID: 27402864
[TBL] [Abstract][Full Text] [Related]
8. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
9. Functional Hierarchy and Cooperation of EMT Master Transcription Factors in Breast Cancer Metastasis.
Addison JB; Voronkova MA; Fugett JH; Lin CC; Linville NC; Trinh B; Livengood RH; Smolkin MB; Schaller MD; Ruppert JM; Pugacheva EN; Creighton CJ; Ivanov AV
Mol Cancer Res; 2021 May; 19(5):784-798. PubMed ID: 33500360
[TBL] [Abstract][Full Text] [Related]
10. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
[TBL] [Abstract][Full Text] [Related]
11. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
Sinh ND; Endo K; Miyazawa K; Saitoh M
Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2.
Cieply B; Riley P; Pifer PM; Widmeyer J; Addison JB; Ivanov AV; Denvir J; Frisch SM
Cancer Res; 2012 May; 72(9):2440-53. PubMed ID: 22379025
[TBL] [Abstract][Full Text] [Related]
13. Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression.
Xiang X; Deng Z; Zhuang X; Ju S; Mu J; Jiang H; Zhang L; Yan J; Miller D; Zhang HG
PLoS One; 2012; 7(12):e50781. PubMed ID: 23284647
[TBL] [Abstract][Full Text] [Related]
14. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
15. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer.
Yamamoto M; Sakane K; Tominaga K; Gotoh N; Niwa T; Kikuchi Y; Tada K; Goshima N; Semba K; Inoue JI
Cancer Sci; 2017 Jun; 108(6):1210-1222. PubMed ID: 28371195
[TBL] [Abstract][Full Text] [Related]
17. AKT-ions with a TWIST between EMT and MET.
Tang H; Massi D; Hemmings BA; Mandalà M; Hu Z; Wicki A; Xue G
Oncotarget; 2016 Sep; 7(38):62767-62777. PubMed ID: 27623213
[TBL] [Abstract][Full Text] [Related]
18. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
19. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
[TBL] [Abstract][Full Text] [Related]
20. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
